Cargando…
Oncogenic RAS Mutants Confer Resistance of RMS13 Rhabdomyosarcoma Cells to Oxidative Stress-Induced Ferroptotic Cell Death
Recent genomic studies revealed a high rate of recurrent mutations in the RAS pathway in primary rhabdomyosarcoma (RMS) samples. In the present study, we therefore investigated how oncogenic RAS mutants impinge on the regulation of cell death of RMS13 cells. Here, we report that ectopic expression o...
Autores principales: | Schott, Christina, Graab, Ulrike, Cuvelier, Nicole, Hahn, Heidi, Fulda, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476278/ https://www.ncbi.nlm.nih.gov/pubmed/26157704 http://dx.doi.org/10.3389/fonc.2015.00131 |
Ejemplares similares
-
Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma
por: Graab, Ulrike, et al.
Publicado: (2015) -
Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence
por: Li, Jenny J., et al.
Publicado: (2021) -
Hedgehog Inhibitors in Rhabdomyosarcoma: A Comparison of Four Compounds and Responsiveness of Four Cell Lines
por: Ridzewski, Rosalie, et al.
Publicado: (2015) -
Characterization of a New Human Embryonal Rhabdomyosarcoma Cell Line, RMS‐GR
por: Fernández, Juan Emilio, et al.
Publicado: (1998) -
Retrospective analysis of rhabdomyosarcoma (RMS) in children in a single center
por: Li, Meng, et al.
Publicado: (2018)